C15.3
BillableMalignant neoplasm of upper third of esophagus
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C15.3 an HCC code?
Yes. C15.3 maps to Lung and Other Severe Cancers under the CMS-HCC V28 risk adjustment model (and Lung and Other Severe Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C15.3
For C15.3 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C15.3 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C15.3 is the ICD-10-CM diagnosis code for malignant neoplasm of upper third of esophagus. This code represents cancer that has developed in the upper portion of the esophagus (the tube that carries food from the throat to the stomach). This is a serious malignant tumor located in the top third of this organ. C15.3 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of digestive organs (c15-c26).
Under the CMS-HCC V28 risk adjustment model, C15.3 maps to Lung and Other Severe Cancers (HCC 20) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, C15.3 mapped to the same category but with a base RAF weight of 0.973 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Verify the specific location is documented as upper third before assigning this code; if the location is not specified or is in a different section (middle or lower third), use a different C15 code. Because C15.3 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C15.3 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Verify the specific location is documented as upper third before assigning this code; if the location is not specified or is in a different section (middle or lower third), use a different C15 code
- •Ensure you have documentation of histological type and stage when available, as these may be required for complete coding and treatment planning
Clinical Significance
Malignant neoplasm of the upper third of the esophagus is classified as a severe cancer with significantly higher risk adjustment weight than oral cavity cancers. Upper esophageal cancers are predominantly squamous cell carcinomas associated with tobacco and alcohol use, and their proximity to the trachea and great vessels makes treatment particularly complex.
Documentation Requirements
- ✓Pathology-confirmed malignancy with histological type (squamous cell carcinoma vs adenocarcinoma)
- ✓Documentation specifying upper third of esophagus (approximately 15-24 cm from incisors)
- ✓Endoscopic ultrasound or CT staging of depth of invasion
- ✓Assessment of tracheal, aortic, and vertebral invasion
- ✓TNM staging with nodal and metastatic evaluation
- ✓Nutritional status and performance status assessment
Commonly Confused Codes
- •C15.4 — Middle third of esophagus; distinguish upper (cervical) from middle (thoracic) esophagus
- •C15.5 — Lower third of esophagus; the lower third is near the gastroesophageal junction
- •C15.9 — Esophagus, unspecified; avoid when the third of the esophagus is documented
- •C13.0 — Postcricoid region; the postcricoid area is hypopharyngeal, above the esophageal inlet